Business Context and Reporting Period
This Form 8-K reports on the 2024 Annual General Meeting (AGM) of Willis Towers Watson Public Limited Company held on May 22, 2024. The filing details the voting results for director elections, auditor ratification, executive compensation, and share issuance authorities.
Key Financial Metrics
This filing is a current report regarding corporate governance and shareholder voting. It does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics.
Material Changes
There are no material financial changes reported in this document. The primary events are the successful election of the board of directors and the approval of shareholder proposals.
Shareholder Voting Results and Governance
- Attendance: 91,841,782 ordinary shares were present, representing approximately 89.81% of the 102,257,774 shares outstanding as of the March 25, 2024 record date.
- Director Elections: All 11 director nominees were elected. Notable voting statistics include:
- Carl Hess: Received 3,910,459 votes against (approx. 4.6% of votes cast).
- Paul Thomas: Received 4,062,088 votes against (approx. 4.8% of votes cast).
- Other Directors: Received significantly fewer "against" votes, ranging from 191,684 to 1,204,566.
- Auditor Ratification: Shareholders approved the selection of Deloitte & Touche LLP and Deloitte Ireland LLP. 91,717,077 votes were cast in favor versus 64,427 against.
- Executive Compensation: The "Say-on-Pay" proposal was approved with 78,725,921 votes in favor and 8,959,473 votes against (approx. 10.2% against).
- Share Issuance Authority: Shareholders approved the renewal of authority to issue shares up to approximately 20% of issued capital and to opt out of pre-emption rights for issuances up to approximately 10% of issued capital.
Investor Verification Checklist
- Verify the specific reasons for the higher "against" vote percentages for directors Carl Hess and Paul Thomas compared to other nominees.
- Review the full Proxy Statement for details on the executive compensation package that received approximately 10% opposition.
- Confirm the implications of the renewed share issuance authority on potential future dilution.
- Check subsequent filings for the official appointment of the newly elected directors.